CJC-1295 + Ipamorelin
10mg + 5mg / 1 Vial
$55.00
Sale price
$55.00
Regular price
Skip to product information
RESEARCH USE ONLY
For qualified in-vitro laboratory research only. Not for human consumption, veterinary use, clinical, diagnostic, or therapeutic use. Not evaluated by the FDA. Purchasers must be 21 years of age or older.
CJC-1295 + Ipamorelin
$55.00
Sale price
$55.00
Regular price
Bundle & save
3-vial packs 15% off · 5-vial packs 25% off · 10-vial packs 35% off — already applied in pack prices
Certificate of Analysis
CJC-1295 + Ipamorelin
Tested batch: CJC-1295 + Ipamorelin (no DAC) 10mg — 99.76% purity (HPLC-UV), identity confirmed by LC-MS
For laboratory research use only. Not for human consumption.
Same-Day Shipping
Free Shipping $100+
Third-Party Tested
Secure Checkout
U.S. shipping: $8 flat standard (3–5 business days). Orders $100+ ship free. Most in-stock weekday orders are handed to the carrier the same business day.
This research blend combines CJC-1295, a synthetic GHRH analog, with Ipamorelin, a pentapeptide ghrelin-receptor (GHS) agonist. Laboratory research has studied the pair for complementary activity on growth-hormone-axis signaling models. Supplied as lyophilized material for qualified in-vitro research.
Compound specifications: Lyophilized powder in sealed vials. Purity verified at ≥99% by independent third-party HPLC analysis. Store in a cool, dry environment; refrigerate after reconstitution per standard laboratory protocol.
Research use notice
Reserved for qualified in-vitro laboratory research only. Not for human consumption, veterinary use, clinical, diagnostic, or therapeutic use. Purchasers must be 21 years of age or older and accept the Research Use Only Agreement before ordering.
What is CJC-1295 + Ipamorelin?
This research blend combines two of the most studied growth-hormone-axis secretagogues: CJC-1295, a synthetic analog of growth hormone–releasing hormone (GHRH 1-29) with four strategic amino-acid substitutions that resist enzymatic degradation, and Ipamorelin, a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) recognized in the literature as the first highly selective growth-hormone secretagogue.
The pairing is a standard reference combination in GH-axis research because the two compounds act on distinct receptor systems — GHRH receptor and ghrelin/GHS receptor respectively — allowing researchers to study complementary secretagogue signaling in a single preparation. Supplied as high-purity lyophilized material strictly for qualified research use.
Mechanism of Action — Research Overview
CJC-1295 (Modified GRF 1-29) engages the GHRH receptor on pituitary somatotroph models, driving cAMP-mediated growth-hormone-release signaling within endogenous feedback architecture. Ipamorelin engages the growth-hormone secretagogue receptor (GHS-R1a, the ghrelin receptor) and is noted in the literature for its selectivity — stimulating GH-release signaling without the broader hormonal spillover observed with earlier secretagogues in study models.
Research models of the combination examine synergistic amplitude effects on pulsatile GH release: the GHRH-pathway component supporting somatotroph synthesis and priming, the GHS-R1a component amplifying pulse release.
Research Applications
- GHRH/GH/IGF-1 axis signaling research
- Ghrelin-receptor (GHS-R1a) pharmacology studies
- Dual-secretagogue synergy models
- Pulsatile hormone-release research
- Comparative secretagogue-selectivity studies
CJC-1295 + Ipamorelin Specifications
| Format | Lyophilized blend in sealed 3 mL glass vial (10mg CJC-1295 + 5mg Ipamorelin) |
| CJC-1295 | CAS 863288-34-0; formula C165H269N47O46; ≈ 3647.2 g/mol; PubChem CID 91971820; synonyms: Modified GRF(1-29) |
| Ipamorelin | CAS 170851-70-4; formula C38H49N9O5; ≈ 711.9 g/mol; PubChem CID 9831659; synonyms: Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Storage | Store lyophilized at −20°C, sealed, protected from light and moisture. Refrigerate after reconstitution per standard laboratory protocol. |
Laboratory Handling & Storage
Standard lyophilized-peptide handling for both components: sterile technique, PPE, moisture protection, and lot documentation for each batch.
Certificate of Analysis & Quality Assurance
Every batch of CJC-1295 + Ipamorelin is verified by independent analytical testing (identity and purity). The certificate of analysis for the current batch is linked on this page. Documentation of test date and method accompanies each batch.
References
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006. PMID: 16352683
- Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998. PMID: 9849822
Note: CJC-1295 + Ipamorelin is supplied strictly for laboratory research use only. It is not approved for human or veterinary use, and nothing on this page is medical advice or a health claim. All described findings reflect preclinical or published research contexts.
Shipping, Handling & Guarantee
- Fast U.S. shipping: Orders placed before 2:00 PM CT ship the same business day from Minneapolis, MN. Free shipping on orders over $100.
- Lab safety profile: Supplied for laboratory research use only. Handle using appropriate personal protective equipment in a suitable laboratory setting. Not for human or veterinary use.
- Order guarantee: If your order arrives damaged, incorrect, or incomplete, contact us within 48 hours of delivery with photos and we will make it right. See our Return & Refund Policy.
